؉ T-lymphocytes both in vivo and in vitro. Although the Tax protein of HTLV-1 has been strongly implicated as a transforming agent, other virally encoded proteins may also play a role in the transformation process. In addition to the rex and tax genes, the pX region of the HTLV-1 genome contains two open reading frames (pX-I and pX-II) which encode the putative viral accessory proteins known as p12 I , p30 II , and p13 II . Mutations in the ACH molecular clone of HTLV-1 that are predicted to abrogate the expression of p12 I , p13 II and p30 II were constructed. These mutations had no effect on viral replication or the immortalization of primary lymphocytes. Although these proteins are dispensable for viral replication and immortalization in vitro, it remains possible that they alter infection in vivo.
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Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis (17, 20, 30, 32) . In addition to the gag, pol, and env genes common to most retroviruses, the HTLV-1 genome contains a region between env and the 3Ј long terminal repeat (LTR) known as the pX region. The pX region consists of four open reading frames (ORFs), termed pX-I, pX-II, pX-III, and pX-IV, which are alternatively spliced to encode a number of proteins. ORFs pX-IV and pX-III encode the Tax and Rex proteins, which are transcriptional and posttranscriptional regulators of viral gene expression, respectively (3, 13, 21, 22, 34) . ORFs pX-I and pX-II are each found in alternatively singly and doubly spliced transcripts which encode a total of three proteins (6, 24, 26) . The single-and double-spliced transcripts of pX-I both utilize the same splice acceptor site, and both encode a protein of 12 kDa known as p12 I (6, 24, 26) . In addition, the double-spliced form of pX-I contains the coding potential for a 27-kDa protein (termed Rof), although expression of this protein in infected cells remains to be demonstrated (6, 26) . p12 I has distant homology to the bovine papillomavirus (BPV) E5 oncoprotein and has been demonstrated to bind to the 16-kDa subunit of a vacuolar ATPase as well as to the ␤ and ␥ chains of the interleukin 2 (IL-2) receptor (14, 27, 29) . In addition, p12 I localizes to cellular endomembranes and perinuclear regions (26) and is capable of cooperating with the BPV E5 protein in the transformation of mouse cells (14) . The doublespliced transcript of pX-II encodes a protein of 30 kDa known as p30 II (also termed Tof), which localizes to the nucleolus and which has distant homology to the Oct and Pit families of transcription factors (6, 24, 26) . The single-spliced pX-II transcript encodes the p13 II protein, which consists of the last 87 amino acids (aa) of p30 II and which localizes to the nucleus (26) . However, despite these initial characterizations of the pX-I-and pX-II-encoded proteins, little is known about the actual role of p12 I , p30 II , and p13 II in viral replication or in the immortalization of primary lymphocytes.
A molecular clone of HTLV-1 known as ACH, which produces infectious virus particles capable of immortalizing primary human lymphocytes (23) and establishing productive infections in rabbits (10), has been previously described. Mutations in the ACH clone that were predicted to result in the loss of expression of the p12 I , p30
II , and p13 II proteins were constructed (Fig. 1) . The ACH.p12
I mutant contained a deletion of 4 bp of a PstI site as a result of treatment with T4 DNA polymerase, which deletes the adenosine in the conserved AG splice acceptor site utilized by both the single-and double-spliced pX-I transcripts. The ACH.p12 I /p30 II mutant contained a 2-bp deletion resulting in a frameshift mutation at a SacII site located 291 bp into the 725-bp p30 II ORF. In addition to frameshifting the p30 II ORF, this mutation also replaced the last 5 aa of p12 I with 55 aa derived from a third reading frame. As p12 I is predicted to contain two membranespanning domains, it is likely that this mutation disrupted the stability and/or processing of p12 I . The ACH.p30 II mutant contained a linker inserted at the same SacII site, which restored the p12 I ORF and introduced a termination codon into the p30 II ORF. The ACH.p30 II /p13 II mutant, constructed by site-specific PCR mutagenesis, contained a deletion of the initiator methionine codon of p13 II (changing it to a BglII site), as well as the p30 II mutation previously described. The structures of the proviral clones were confirmed by restriction enzyme and nucleotide sequence analyses. These mutations did not affect the ability of the virus to express a functional Tax protein capable of transactivating an HTLV-LTR-luciferase reporter vector when cotransfected with the mutant ACH clones in COS7 or 293T cells (data not shown). In addition, these clones produced comparable amounts of virus particles when transfected in 293T cells with similar Gag and Env protein compositions as determined by Western blotting of concentrated cell culture supernatants with anti-p19 MA monoclonal antibody (MAb) 12/1.2 (provided by M. Robert-Guroff) and anti-gp46 SU envelope MAb 0.5␣ (provided by Y. Matsushita) (data not shown).
These mutants also retained the ability to immortalize primary human peripheral blood mononuclear cells (PBMC). Human PBMC were isolated from normal donors by Ficoll-Paque (Pharmacia, Piscataway, N.J.) centrifugation and activated for 72 h with 10 g of phytohemagglutinin-P (Gibco, Gaithersburg, Md.) per ml and 50 U of IL-2 per ml, after which they were transfected (10 7 cells) with 25 g of the ACH plasmids by electroporation at 250 V and 1,800 F. The transfected cells were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (Gibco), 2 mM glutamine, 100 g of penicillin per ml, 100 U of streptomycin per ml, and 50 U of IL-2 per ml (PBMC growth medium). Cellular proliferation was monitored by MTT conversion assays (19) , and cell culture supernatants were collected for p19
MA dot blot assays. The wild-type (WT) ACH clone (ACH.wt) immortalized the transfected PBMC on three of four attempts, while the ACH.p12 I , ACH.p12 I /p30 II , ACH.p30 II , and ACH.p30 II /p13 II mutants immortalized the transfected cells on three of four, two of four, four of four, and two of two attempts, respectively. The immortalized cell lines derived from these cultures expressed similar amounts of p19
MA antigen in the cell culture supernatants, as determined by dot blot analysis with an anti-p19
MA MAb (12/1.2), which suggests the release of similar numbers of viral particles from the infected cells (data not shown). In addition, the cell lines expressed the cell surface markers CD3, CD4, and CD25 but lacked expression of CD8, consistent with an activated T-helper-cell phenotype (data not shown).
To confirm that the mutations were present in the integrated proviral DNA, a portion of the pX region was amplified by PCR from genomic DNA from the immortalized cell lines. A 937-bp PCR product was amplified from the genomic DNA from the ACH-immortalized cell lines, but not from uninfected PBMC (Fig. 2 ). The PCR product was then digested with restriction endonucleases (New England Biolabs, Beverly, Mass.) which were diagnostic for the presence or absence of the various mutations (Fig. 2) . The ACH.p12 I mutation deleted a PstI site, while the ACH.p12 I /p30 II mutation deleted a SacII site in the fragment. The ACH.p30 II mutation added an XbaI site, and the ACH.p30 II /p13 II mutation added both an XbaI site and a BglII site. According to this analysis, the cell lines examined all contained the original expected mutations in the integrated proviral genome.
To further confirm the presence of the ACH.p12 I and ACH.p30 II mutations in the proviruses of the immortalized cell lines, two separate strategies were employed. As the ACH.p12
I mutant contains a splice acceptor site deletion, reverse transcription-PCR (RT-PCR) was performed on total RNA isolated from the ACH.wt-and ACH.p12 I -immortalized cell lines to confirm the absence of the p12 I double-spliced product (Fig. 3A) . The primer pair utilized amplifies both a 2,041-bp fragment corresponding to the gag-pol and env transcripts and a 490-bp fragment corresponding to the doublespliced pX-I transcript. The PCR products were separated on a 1% agarose gel, transferred to a nylon membrane, and probed with a digoxigenin (Boehringer Mannheim, Indianapolis, Ind.)-labelled probe derived from the pX-I ORF. Whereas the 2,041-bp fragment was present in both the ACH.wt and ACH.p12 I clones, the 490-bp pX-I fragment was only detected in the ACH.wt-immortalized cells. This analysis also confirmed the lack of additional cryptic p12 I mRNA splice sites, which could be functioning in the absence of the preferred p12 I splice acceptor site, as additional spliced transcripts would have been detected by this probe. This analysis does not, however, exclude the unlikely possibility that the p12 I protein could be expressed from a polycistronic message. To assess this possibility, we introduced a polynucleotide linker coding for the influenza hemagglutinin epitope at the 3Ј end of the p12 I ORF in the ACH.wt and ACH.p12 I clones. However, we were un- able to detect the expression of the tagged p12 I protein with either clone in transiently transfected 293T cells by Western blotting or radioimmunoprecipitation (data not shown). This is most likely due to the low level of expression of the p12 I transcript and is consistent with the fact that the translated p12 I protein has not yet been detected in HTLV-1-infected cells (6, 24) .
To confirm the ACH.p30 II mutation in the immortalized cell lines, the p30 II ORF was amplified by PCR from both the original plasmid and from the genomic DNA from the ACH.wtand ACH.p30 II -immortalized cell lines, cloned into the pTM3 expression plasmid (which places the p30 II ORF under the control of the T7 promoter) (16), and expressed in vitro with the TNT-coupled reticulocyte lysate system (Promega, Madison, Wis.). Only the p30 II ORF derived from the ACH.wt plasmid or genomic DNA expressed a 30-kDa product, while the product was absent from the ACH.p30
II plasmid-and immortalized-cell DNA-derived expression vectors (Fig. 3B) .
As the p12 I protein has been demonstrated to bind to the IL-2 receptor ␤ and ␥ chains (29) (Fig. 4) . Finally, long term cultures in gradually decreasing concentrations of IL-2 also revealed no difference in IL-2 dependency, with all cell lines remaining dependent on 3 to 6 U of IL-2 per ml after 6 months in culture (data not shown).
To confirm that the immortalized cell lines were producing virus which was infectious and capable of immortalizing uninfected PBMC, 5 ϫ 10 5 ACH.wt-, ACH.p12 I -, ACH.p12 I /p30 II -, and ACH.p30
II -immortalized cells were exposed to lethal gamma radiation (6,000 rads) and cocultured in PBMC growth medium with 4 ϫ 10 6 uninfected, activated PBMC and cell viability was monitored by a MTT conversion assay (19) . The PBMC alone proliferated for a short period of time, and the irradiated cells alone did not proliferate. In contrast, the cocultured cells continued to proliferate indefinitely, indicating the productive infection and immortalization of the uninfected cells (Fig. 5) .
To further quantify the infectivity and immortalizing ability of these mutants, we employed a microtiter infectivity/immortalization assay as described by Persaud et al. (31) . In this assay, 10 4 uninfected activated PBMC were cocultured in PBMC growth medium with 10-fold dilutions (10 4 , 10 3 , 10 2 , and 10) of lethally gamma-irradiated (6,000 rads) ACH mutant-immortalized cells in replicates of 10 to 20 in 96-well microtiter plates. The numbers of cultures which became immortalized were then determined at 9 to 16 weeks after the coculture by microscopic examination of the individual wells. The results of this analysis indicated that the viruses from the ACH.p12 I , ACH.p12 I /p30 II , ACH.p30 II , and ACH.p30 II /p13 II mutant-immortalized cell lines were all capable of infecting and immortalizing the uninfected PBMC with relatively similar efficiencies at the different dilutions of infected cells (Table 1) . Furthermore, additional microtiter assays with the ACH.p12 I mutant in decreasing concentrations of IL-2 (50, 10, and 2 U/ml) again revealed no difference in immortalizing activity compared to the ACH.wt clone, with 50 U of IL-2 per ml being required for the immortalization of uninfected PBMC for both the WT and p12 I mutant (data not shown). , p30  II ,  and p13 II proteins could affect viral replication in a cell-typespecific manner, as has been observed with other retroviral accessory proteins (i.e., human immunodeficiency virus type 1 Vpr and equine infectious anemia virus dUTPase are required for viral replication in quiescent macrophages but not in dividing cells) (1, 11, 36) .
HTLV-1-infected T-cell lines which have become IL-2 independent as well as uncultured lymphocytes from adult T-cell leukemia/lymphoma patients often acquire constitutively activated Jak-STAT signalling pathways (28, 35, 39) . This is particularly interesting in light of the fact that p12 I has been demonstrated to bind the ␤ and ␥ chains of the IL-2 receptor (29) and IL-2 signalling is associated with the phosphorylation of STAT proteins (15) . Although we do not find an influence of the p12 I protein on the IL-2 requirements for proliferation or immortalization in the ACH-immortalized (IL-2 dependent) cell lines, it remains an intriguing possibility that p12 I may be necessary for the acquisition of IL-2 independence, either by altering IL-2 receptor signalling or through another unknown mechanism.
The pX regions of the closely related HTLV-2 and bovine leukemia viruses (BLV) also contain a number of spliced ORFs which have varying degrees of homology to the pX-I and pX-II ORFs of HTLV-1 (7, 18, 37) . The pX-I ORF of HTLV-2 encodes a nucleolar protein designated p10 xI which is 56% similar and 37% identical to the p12 I protein (7, 18) . The HTLV-2 pX-II ORF encodes a protein known as p28 xII which has little or no homology to p30 II (7, 18) . The HTLV-2 pX-I and pX-II ORFs were previously found to be dispensable for viral replication and immortalization in vitro (18) . However, these HTLV-2 ORFs were subsequently shown to be important for viral replication in a rabbit model of HTLV-2 infection (8). Likewise, the R3 and G4 ORFs of BLV, which are also distantly homologous to pX-I and pX-II, were shown to be important for the maintenance of high viral loads in sheep (37, 38) . Preliminary results with a rabbit model of HTLV-1 infection have indicated that virus derived from the ACH.p12
I mutant is incapable of establishing a productive infection in rabbits, implying a role for p12 I in viral replication in vivo (9). Therefore, it remains possible that the HTLV-1 p30 II and p13 II proteins are also playing a role in viral infectivity or replication in vivo. 
